Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Clinical trial NCT00171301 · COMPLETED

Trial details

NCT number: NCT00171301
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Beta-thalassemia Major Hemosiderosis Iron Overload Rare Anemia

Start date: 2005-06-01
Primary completion: 2008-05-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.